SF3B1 and cancer: Third, substitutions/deletions of the critical residues in SUGP1, including naturally occurring cancer mutations, recapitulated the RNA missplicing induced by SF3B1 cancer mutations that were previously shown to disrupt SF3B1 interaction with SUGP1 (Zhang et al. 2019a).